Effectiveness of COVID-19 treatment with nirmatrelvir–ritonavir or molnupiravir among US veterans: target trial emulation studies with one-month and six-month …

KL Bajema, K Berry, E Streja, N Rajeevan… - Annals of internal …, 2023 - acpjournals.org
Background: Information about the effectiveness of oral antivirals in preventing short-and
long-term COVID-19–related outcomes in the setting of Omicron variant transmission and …

Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among US Veterans: Target Trial Emulation Studies With One-Month and Six-Month …

KL Bajema, K Berry, E Streja… - Annals of internal …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Information about the effectiveness of oral antivirals in preventing short-and
long-term COVID-19-related outcomes in the setting of Omicron variant transmission and …

Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among US Veterans: target trial emulation studies with one-month and six-month …

KL Bajema, K Berry, E Streja, N Rajeevan, Y Li, L Yan… - 2022 - pesquisa.bvsalud.org
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among US
Veterans: target trial emulation studies with one-month and six-month outcomes …

[HTML][HTML] Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among US Veterans: target trial emulation studies with one-month and six …

KL Bajema, K Berry, E Streja, N Rajeevan, Y Li, L Yan… - 2022 - europepmc.org
Background Information about the effectiveness of oral antivirals in preventing short-and
long-term COVID-19-related outcomes during the Omicron surge is limited. We sought to …

[HTML][HTML] Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among US Veterans: target trial emulation studies with one-month and six …

KL Bajema, K Berry, E Streja, N Rajeevan, Y Li, L Yan… - medRxiv - ncbi.nlm.nih.gov
Background: Information about the effectiveness of oral antivirals in preventing short-and
long-term COVID-19-related outcomes during the Omicron surge is limited. We sought to …

Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among US Veterans: target trial emulation studies with one-month and six-month …

KL Bajema, K Berry, E Streja, N Rajeevan, Y Li, L Yan… - medRxiv, 2022 - medrxiv.org
Background Information about the effectiveness of oral antivirals in preventing short-and
long-term COVID-19-related outcomes during the Omicron surge is limited. We sought to …

Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among US Veterans: Target Trial Emulation Studies With One-Month and Six-Month …

KL Bajema, K Berry, E Streja… - Annals of internal …, 2023 - pure.johnshopkins.edu
BACKGROUND: Information about the effectiveness of oral antivirals in preventing short-and
long-term COVID-19-related outcomes in the setting of Omicron variant transmission and …

Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among US veterans: target trial emulation studies with one-month and six-month …

KL Bajema, K Berry, E Streja, N Rajeevan, Y Li… - 2023 - cabidigitallibrary.org
Background: Information about the effectiveness of oral antivirals in preventing short-and
long-term COVID-19-related outcomes in the setting of Omicron variant transmission and …

Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among US Veterans: Target Trial Emulation Studies With One-Month and Six-Month …

KL Bajema, K Berry, E Streja, N Rajeevan… - Annals of internal …, 2023 - escholarship.org
BackgroundInformation about the effectiveness of oral antivirals in preventing short-and long-
term COVID-19-related outcomes in the setting of Omicron variant transmission and COVID …

Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among US Veterans: Target Trial Emulation Studies With One-Month and Six-Month …

KL Bajema, K Berry, E Streja, N Rajeevan… - Annals of Internal …, 2023 - europepmc.org
Background Information about the effectiveness of oral antivirals in preventing short-and
long-term COVID-19-related outcomes in the setting of Omicron variant transmission and …